Stock 2616 CSTONE PHARMACEUTICALS
Add to a list
To use this feature you must be a member
Log inSign up

Consensus CStone Pharmaceuticals

Equities

2616

KYG2588M1006

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:20 2024-05-14 am EDT 		5-day change 1st Jan Change
1.1 HKD +1.85% Intraday chart for CStone Pharmaceuticals +1.85% -51.54%
May. 06 Cstone Pharmaceuticals To Present Cancer Results at 2024 ASCO MT
May. 02 Non-Executive Director Increases Shareholding in CStone Pharma; Shares Surge 25% MT

Evolution of the average Target Price on CStone Pharmaceuticals

Price target over the last 5 years

History of analyst recommendation changes

d5.wYMnuXy8aB2pe9AJlSMXC_OyimNLLangw8VExMWHVhw.9fZR8kTEL3foQ6ZH4koiScfl7BA8YfaY9KAB_YPkHFaDwRGAEYwhT9EZ6A~ef003c4ed972708c45ad92011dfd7f9f

Analyst Recommendations on CStone Pharmaceuticals

Non-Executive Director Increases Shareholding in CStone Pharma; Shares Surge 25% MT
Cstone Pharmaceuticals’ CEO Boosts Stakeholding MT
CStone Pharma's Investigational Antibody Boosts Objective Response Rate of Lymphoma Patients in Clinical Trial MT
CStone Announces Phase 2 GEMSTONE-201 Trial Met Primary Endpoint of Objective Response Rate in Patients with Relapsed or Refractory Extranodal Natural Killer/T-Cell Lymphoma (R/R ENKTL) CI
CStone's Anti-PD-L1 Antibody Demonstrates a Complete Response Rate of 31.8% in Patients With Relapsed or Refractory Extra nodal Natural Killer/T-Cell Lymphoma CI
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
1.018 CNY
Average target price
3.186 CNY
Spread / Average Target
+212.91%
High Price Target
3.675 CNY
Spread / Highest target
+260.88%
Low Price Target
2.698 CNY
Spread / Lowest Target
+164.94%

Consensus detail

Consensus revision (last 18 months)

Ratings for CStone Pharmaceuticals

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. 2616 Stock
  4. Consensus CStone Pharmaceuticals
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW